MedTrace Logo

A Registry Study to Evaluate Outcomes of PEMF Therapy in Subjects With Various Pain Etiologies

NCT02881112 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 180

Last updated 2020-04-06

Study results available
· View outcomes & findings →

Summary

The study is an open-label, non-controlled study of the safety and effectiveness of investigator determined Provant therapy in subjects with pain and/or edema from various pain etiologies. Information collected in the study will be entered into a registry database.

Conditions

Interventions

DEVICE

Provant Therapy System

Treatment with the Provant Therapy System

Sponsors & Collaborators

  • Regenesis Biomedical, Inc.

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
22 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-03-31
Primary Completion
2017-12-14
Completion
2017-12-14

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02881112 on ClinicalTrials.gov